-
Symbol
-
BTAI on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
5M shares
-
Security Ownership
-
9.99%
Armistice Capital, LLC ownership in BioXcel Therapeutics, Inc. Common Stock, $0.001 par value per share (BTAI)
2025-02-14 - Armistice Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5M shares of BioXcel Therapeutics, Inc. Common Stock, $0.001 par value per share (BTAI).
This represents 9.99% percent ownership of the company.